5-Aziridino-2,4-dinitrobenzamide
5-Aziridino-2,4-dinitrobenzamide Basic information
- Product Name:
- 5-Aziridino-2,4-dinitrobenzamide
- Synonyms:
-
- CB 1954;CB-1954
- 5-(1-aziridinyl)-2,4-dinitrobenzamide
- NSC 115829
- tretazicar
- 5-(1-Aziridinyl)-2,4-dinitrobenzamide, 5-(Aziridin-1-yl)-2,4-dinitrobenzamide
- 5-Aziridino-2,4-dinitrobenzamide
- 2,4-Dinitro-5-(aziridine-1-yl)benzamide
- CB-954
- CAS:
- 21919-05-1
- MF:
- C9H8N4O5
- MW:
- 252.18
- Mol File:
- 21919-05-1.mol
5-Aziridino-2,4-dinitrobenzamide Chemical Properties
- Melting point:
- 173 °C
- Boiling point:
- 427.2±45.0 °C(Predicted)
- Density
- 1.671±0.06 g/cm3(Predicted)
- storage temp.
- -20°C
- solubility
- Acetonitrile (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
- form
- solid
- pka
- 14.23±0.50(Predicted)
- color
- Yellow to Dark Yellow
- InChIKey
- WOCXQMCIOTUMJV-UHFFFAOYSA-N
5-Aziridino-2,4-dinitrobenzamide Usage And Synthesis
Description
CB-1954 is a prodrug that is enzymatically activated to generate an antitumor agent that forms DNA-DNA interstrand crosslinks. In rat Walker 256 carcinoma cells, CB-1954 is reduced by NAD(P)H:quinone oxidoreductase (NQO1) to the cytotoxic derivative 5-(aziridin-1-yl)-4-hydroxylamineo 2 nitrobenzamide, a bifunctional alkylating agent.
Uses
5-Aziridino-2,4-dinitrobenzamide is an anticancer prodrug used in gene therapy research and is known to be activated by NAD(P)H Quinone Oxidoreductase 2.
Uses
Tretazicar is an anticancer prodrug used in gene therapy research and is known to be activated by NAD(P)H Quinone Oxidoreductase 2.
Biochem/physiol Actions
CB 1954 is an anticancer prodrug used in gene therapy research; activated by NAD(P)H quinone oxidoreductase?2.
in vivo
Tretazicar (CB 1954) (80 mg/kg; i.p. on days 2 and 9) results in a significant increase in survival[3].
| Animal Model: | Female BALB/c mice (AB22-nr, SKOV3 human ovarian tumour xenograft)[3] |
| Dosage: | 80 mg/kg |
| Administration: | i.p. on days 2 and 9 |
| Result: | The median survival of the AB22-nr was 49 days. Resulted in a significant increase in survival. |
References
[1] R J KNOX. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.[J]. Cancer research, 2000, 60 15: 4179-4186.
5-Aziridino-2,4-dinitrobenzamideSupplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- +86 21 61551611
- Tel
- 025-66113011 17798518460
- cfzhang@aikonchem.com
- Tel
- 03-36680489
- Sales-JP@TCIchemicals.com